Chinese capital accesses Western innovation to create homegrown industry

February 9, 2017 Christoph Graener

With the Chinese market growing at 10–15% a year, it is poised to be world’s largest by 2026. Tony Chu, co-founder and managing partner at consultants TPP Healthcare, explains to Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, how Chinese capital is accessing Western innovation to build a PRC pharma industry.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Tony Chu – Founding Partner, TPP Healthcare

Previous Article
Rexgenero readies cell therapy for Critical Limb Ischemia Phase III

Rexgenero CEO Dr. Joe Dupere says that the London-based cell therapy company is seeking new investors and p...

Next Article
Increase the value of your asset: Think with the end in mind
Increase the value of your asset: Think with the end in mind

Developing a drug is a very long journey, therefore it is critical to define the destination upfront. The T...